Budapest, Hungary

Mihaly Sajgo

This inventor holds 1 USPTO granted patent. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mihaly Sajgo. Retrieved from https://idiyas.com/inventor/mihaly-sajgo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mihaly Sajgo and His Patent on a Biologically Active Substance

Introduction

Mihaly Sajgo is an inventor associated with Budapest, Hungary, and Richter Gedeon Vegyeszeti Gyar Rt. His recorded patent work concerns a biologically active substance that can be isolated from normal white blood cells.

Latest Patents

Sajgo is associated with 1 patent, titled “Process for the Preparation of a Biologically Active Substance.” The invention describes a process for preparing a peptide capable of selectively inhibiting the proliferation of normal and leukemic myeloid cells. The patent characterizes the substance by its amino acid composition, charge, electrophoretic mobility, and positive chloro-toluidine reaction.

Career Highlights

The patent reflects research into biologically active compounds and their potential effects on myeloid cells. Sajgo’s listed company affiliation is Richter Gedeon Vegyeszeti Gyar Rt.

Collaborations

Sajgo’s listed coworkers include Lajos Kisfaludy and Kornelia Barabas Nee Borbas.

Conclusion

Mihaly Sajgo’s recorded invention focuses on preparing and characterizing a peptide with selective inhibitory activity against normal and leukemic myeloid cells.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…